5'-iodoindirubin has been researched along with indirubin-3'-monoxime in 4 studies
*indirubin-3'-monoxime: has antiangiogenic activity [MeSH]
*indirubin-3'-monoxime: has antiangiogenic activity [MeSH]
Studies (5'-iodoindirubin) | Trials (5'-iodoindirubin) | Recent Studies (post-2010) (5'-iodoindirubin) | Studies (indirubin-3'-monoxime) | Trials (indirubin-3'-monoxime) | Recent Studies (post-2010) (indirubin-3'-monoxime) |
---|---|---|---|---|---|
6 | 0 | 1 | 139 | 0 | 82 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greengard, P; Leost, M; Magiatis, P; Meijer, L; Mikros, E; Musacchio, A; Myrianthopoulos, V; Pearl, L; Polychronopoulos, P; Roe, SM; Skaltsounis, AL; Tarricone, A | 1 |
Grundt, P; Jones-Brando, L; Krivogorsky, B; Yolken, R | 1 |
Choi, SJ; Choi, SU; Han, SY; Kim, YC; Lee, SD; Moon, MJ | 1 |
Byun, BJ; Choi, G; Choi, SU; Jung, ME; Kim, HM; Kim, SJ; Kim, YC; Lee, JY; Lee, K; Lee, N; Park, JH; Son, YH; Yang, KM | 1 |
4 other study(ies) available for 5'-iodoindirubin and indirubin-3'-monoxime
Article | Year |
---|---|
Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases.
Topics: Cyclin-Dependent Kinases; Glycogen Synthase Kinase 3; Indoles; Models, Molecular; Oximes; Structure-Activity Relationship | 2004 |
Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.
Topics: Animals; Antiprotozoal Agents; Drugs, Chinese Herbal; Indoles; Isatis; Parasitic Sensitivity Tests; Quinazolines; Toxoplasma | 2008 |
Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Leukemia, Myeloid, Acute | 2010 |
Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening.
Topics: Apoptosis Regulatory Proteins; Dose-Response Relationship, Drug; Drug Discovery; High-Throughput Screening Assays; Humans; Indoles; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Structure-Activity Relationship | 2016 |